62
Views
11
CrossRef citations to date
0
Altmetric
Original Article

A Combined Histochemical and Double Immunohistochemical Labeling Protocol for Simultaneous Evaluation of Four Cellular Markers in Restenotic Arteries

, , &
Pages 172-180 | Published online: 12 Jul 2009

References

  • Bendeck M. P., Irvin C., Reidy M. A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res 1996; 78: 38–43
  • Cheung W. ‐M., D'Andrea M. R., Andrade‐Gordon P., Damiano B. P. Vascular injury response in thrombin receptor (PAR‐1) deficient mice. Arterioscler. Thromb. Vasc. Biol. 1999, In press
  • Clowes A. W., Reidy M. A., Clowes M. M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest 1983; 49: 327–333
  • D'Andrea M. R. The Expression and Intracellular Localization of DNA Topoisomerase IIβ in Normal and Neoplastic Human Cells. Rutgers University, New Brunswick, NJ 1998, Dissertation
  • D'Andrea M. R., Derian C. K., Leturcq D., Baker S. M., Brunmark A., Ling P., Darrow A. L., Santulli R. J., Brass L. F., Andrade‐Gordon P. Characterization of protease activated receptor (PAR‐2) immunoreactivity in normal human tissues. J. Histochem. Cytochem. 1998; 46: 157–164
  • D'Andrea M. R., Farber P. A., Foglesong P. D. Immunohistochemical detection of DNA topoisomerases IIα and IIβ compared with detection of Ki‐67, a marker of cellular proliferation, in human tumors. Appl. Immunohistochem 1994; 2: 177–185
  • Holm J., Hansson G. K. Cellular and immunologic features of carotid artery disease in man and experimental animal models. Eur. J. Vasc. Surg 1990; 4: 49–55
  • Igura T., Kawata S., Miyagawa J. ‐I., Inui Y., Tamura S., Fukuda K., Isozaki K., Yamamori K., Taniguchi N., Higashiyama S., Matsuzawa Y. Expression of heparin‐binding epidermal growth factor‐like growth factor in neointimal cells induced by balloon injury in rat carotid arteries. Arterioscler. Thromb. Vasc. Biol 1996; 16: 1524–1531
  • Johansson L., Holm J., Hansson G. K. Smooth muscle cells express Ia antigens during arterial response to injury. Lab. Invest 1988; 58: 310–315
  • Koyama H., Reidy M. A. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ. Res 1997; 80: 408–417
  • Mattsson E., Clowes A. W. Current concepts in restenosis following balloon angioplasty. Trend. Cardiovasc. Med 1995; 5: 200–204
  • Reidy M. A. A reassessment of endothelial injury and arterial lesion formation. Lab. Invest 1985; 53: 513–520
  • Reilly C. F., Fujita T., McFall R. C., Stabilito I. I., Eng W., Johnson R. Pharmacological and mechanistic aspects concerning the use of heparin and β‐cyclodextin tetradecasulfate for the treatment of vascular restenosis. Drug Dev. Res 1993; 29: 137–147
  • Sakai A., Kume N., Nishi E., Tanoue K., Miyasaka M., Kita T. P‐selectin and vascular cell adhesion molecule‐1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T‐lymphocytes. Arterioscler. Thromb. Vasc. Biol 1997; 17: 310–316
  • Zempo N., Koyama N., Kenagy R. D., Lea H. J., Clowes A. W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol 1996; 16: 28–33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.